Drug delivery company, Nemera, has received drug manufacturing authorisation from the German Government Drug Administration (Government Presidium, Tübingen) for its Neuenburg plant.
Authorised
This authorisation means that the company can now handle, assemble, sterilise and store pharmaceutical drugs and medicinal products for autoinjectors at the plant.
“Achieving this pharmaceutical drug manufacturing approval is highlighting our commitment to ensure the safety of our drug delivery devices for the benefit of patients. It is also the confirmation that our quality systems and processes are meeting consistently regulatory requirements and patient expectations,” commented Christian Meusinger, quality vice-president of Nemera.
The pharmaceutical drug manufacturing certification is a required regulatory step, in order to allow Nemera to provide a complete set of services and additional support, for the development and manufacture of pharmaceutical combination products and drug delivery devices to customers
